This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Michigan. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ruiting Li: Innovator in Viral Infection Treatment
Introduction
Ruiting Li is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Ruiting Li holds a patent for "Remdesivir and remdesivir analogs, solutions, and nanoparticle, liposomal, and microparticle compositions for treating viral infections." This invention focuses on methods, compounds, and compositions aimed at treating viral infections, including COVID-19. The patent outlines various embodiments of the compositions, which may include remdesivir analogs, surfactants, cyclodextrins, nanoparticles, liposomes, and microparticles. These compositions can be administered in different forms, such as aqueous solutions for intravenous use or as nebulized dry powders for inhalation.
Career Highlights
Ruiting Li is affiliated with the University of Michigan, where he continues to advance his research and innovation in the medical field. His work has garnered attention for its potential impact on public health, especially during the ongoing challenges posed by viral infections.
Collaborations
Ruiting Li collaborates with notable colleagues, including Duxin Sun and Wei Gao. These partnerships enhance the research and development of effective treatments for viral infections.
Conclusion
Ruiting Li's contributions to the field of viral infection treatment through his innovative patent demonstrate his commitment to improving health outcomes. His work at the University of Michigan and collaborations with esteemed colleagues further solidify his role as a key inventor in this critical area of research.